These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8198628)

  • 1. Nylestriol replacement therapy in postmenopausal women. A three-year prospective study.
    Cheng GJ; Liu JL; Zhang Q; Fan W; Ye HF; Wang ZQ; Pan HP
    Chin Med J (Engl); 1993 Dec; 106(12):911-6. PubMed ID: 8198628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective double-blind study of CEE3 in peri- and postmenopausal women: effects on bone loss and lipoprotein lipids.
    Cheng GJ; Liu JL; Zhang Q; Ye HF; Wang ZQ; Pan HP
    Chin Med J (Engl); 1992 Nov; 105(11):929-33. PubMed ID: 1304463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A prospective study of nylestriol on plasma lipids in postmenopausal women].
    Cheng GJ
    Zhonghua Fu Chan Ke Za Zhi; 1991 Nov; 26(6):349-51, 387-8. PubMed ID: 1804605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prospective study on nylestriol replacement therapy in postmenopausal women].
    Cheng GJ
    Zhonghua Fu Chan Ke Za Zhi; 1993 Sep; 28(9):534-8, 569. PubMed ID: 8313746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of low dose nylestriol-levonorgestrel replacement therapy on bone mineral density in women with postmenopausal osteoporosis.
    Liao EY; Luo XH; Deng XG; Wu XP; Liao HJ; Wang PF; Mao JP; Zhu XP; Huang G; Wei QY
    Endocr Res; 2003 May; 29(2):217-26. PubMed ID: 12856809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
    Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone metabolism in postmenopausal women and after estrogen treatment].
    Song SJ
    Zhonghua Fu Chan Ke Za Zhi; 1993 Feb; 28(2):79-81, 122. PubMed ID: 8344086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the lipoprotein profile in postmenopausal women receiving hormone replacement therapy. Effects of natural and synthetic progesterone.
    Chen FP; Lee N; Soong YK
    J Reprod Med; 1998 Jul; 43(7):568-74. PubMed ID: 9693406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-year study of estrogen alone versus combined with progestin in postmenopausal women with or without hypercholesterolemia.
    Sanada M; Nakagawa H; Kodama I; Sakasita T; Ohama K
    Metabolism; 2000 Jun; 49(6):784-9. PubMed ID: 10877207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women.
    Balci H; Altunyurt S; Acar B; Fadiloglu M; Kirkali G; Onvural B
    Maturitas; 2005 Apr; 50(4):289-93. PubMed ID: 15780528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
    Davidson MH; Testolin LM; Maki KC; von Duvillard S; Drennan KB
    Arch Intern Med; 1997 Jun; 157(11):1186-92. PubMed ID: 9183229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of dietary intervention alone or combined with hormone replacement therapy in postmenopausal women with hypercholesterolemia in Seoul, Korea.
    Jung K; Kim S; Woo J; Chang Y
    Eur J Nutr; 2002 Jun; 41(3):101-7. PubMed ID: 12111046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women].
    Imperato F; Marziani R; Perniola G; Ebano V; Fruscella M; Mossa B
    Minerva Ginecol; 2003 Feb; 55(1):87-93. PubMed ID: 12598849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].
    Milewicz T; Kostecka A; Rogatko I; Sztefko K; Kwiatkowska-Panek E; Radowick S; Krzysiek J
    Przegl Lek; 2007; 64(2):65-9. PubMed ID: 17892034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.
    Jolly EE; Bjarnason NH; Neven P; Plouffe L; Johnston CC; Watts SD; Arnaud CD; Mason TM; Crans G; Akers R; Draper MW
    Menopause; 2003; 10(4):337-44. PubMed ID: 12851517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between sex hormone levels and blood lipids/immunity in perimenopausal women].
    Ma Q; Zhou H; Sun M; Wu S
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(5):461-4. PubMed ID: 10682561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.